Neuroblastoma cells may suffer genetic damage; the MYCN gene is a proto-oncogene that is amplified in more than 10 copies in 20–30% of cases, and it was associated with aggressive disease and poor outcome [1,3,7,16]. The gene discussed is MYCN; the disease is neuroblastoma.